Background: Lipodystrophy (LD) syndromes are a group of rare disorders that affect how a person s body can store and use fat tissue. Many people with LDs beco…

Insulin Receptor MutationPartial Lipodystrophy

~Estimated

~$10 – $5,625

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NCT05470504

MEASuRE: Metreleptin Effectiveness And Safety Registry

The study is a post-authorization, prospective, voluntary registry of patients treated with commercial metreleptin including, but not limited to, patients in t…

Generalised LipodystrophyPartial Lipodystrophy

~Estimated

~$10 – $1,125

Chiesi Farmaceutici S.p.A.NCT02325674

Phase 3

An Open-label Extension of APG-20 Study to Evaluate the Long-term Safety and Efficacy of Daily Subcutaneous Metreleptin Treatment in Subjects With Partial Lipodystrophy

This Phase 3 study is an Open Label Extension of the APG-20 Study To Evaluate the Long-term Safety and Efficacy of Daily Subcutaneous Metreleptin Treatment in …

Familial Partial Lipodystrophy

~Estimated

~$10 – $7,500

Chiesi Farmaceutici S.p.A.NCT06679270